Table 1. Baseline characteristics of RA... | American Society of Hematology

Table 1.

Baseline characteristics of RA patients treated with cA2

	Nonanemic (n = 17)	ACD patients (n = 15)	IDA patients (n = 8)	All patients (n = 40)
Clinical data
Age (median, range)	44 (30-61)	48 (26-74)	48 (18-67)	48 (18-74)
Sex (female/male)	14/3	6/9	8/0	28/12
Disease duration (mo)	141 ± 112^*	125 ± 73	118 ± 54	131 ± 88
Number of swollen joints	42 ± 14	28 ± 9	43 ± 10	37 ± 14
HAQ score	1.27 ± 0.57	0.96 ± 0.48	0.87 ± 0.65	1.07 ± 0.57
Laboratory variables
Hemoglobin, g/dL	13.24 ± 0.71	11.42 ± 1.31	11.02 ± 0.6	12.09 ± 1.34
MCV, fl	88.03 ± 5.16	81.75 ± 9.46	72.77 ± 9.74	82.63 ± 9.64
Serum iron, μmol/L	71.6 ± 36.6	30.8 ± 12.3	39.1 ± 23.6	49.8 ± 32.8
Ferritin, ng/mL	47.82 ± 26.41	109.88 ± 98.0	15.15 ± 10.11	62.71 ± 73.16
ESR, mm/h	39 ± 23	51 ± 18	63 ± 18	48 ± 22
CRP, mg/dL	1.38 ± 1.56^*	3.57 ± 4.12	2.12 ± 2.12	2.35 ± 2.98
RF (positive)	9	8	6	23
Medication
Methotrexate^†	17	15	8	40
Corticosteroids^‡	4	5	2	11

	Nonanemic (n = 17)	ACD patients (n = 15)	IDA patients (n = 8)	All patients (n = 40)
Clinical data
Age (median, range)	44 (30-61)	48 (26-74)	48 (18-67)	48 (18-74)
Sex (female/male)	14/3	6/9	8/0	28/12
Disease duration (mo)	141 ± 112^*	125 ± 73	118 ± 54	131 ± 88
Number of swollen joints	42 ± 14	28 ± 9	43 ± 10	37 ± 14
HAQ score	1.27 ± 0.57	0.96 ± 0.48	0.87 ± 0.65	1.07 ± 0.57
Laboratory variables
Hemoglobin, g/dL	13.24 ± 0.71	11.42 ± 1.31	11.02 ± 0.6	12.09 ± 1.34
MCV, fl	88.03 ± 5.16	81.75 ± 9.46	72.77 ± 9.74	82.63 ± 9.64
Serum iron, μmol/L	71.6 ± 36.6	30.8 ± 12.3	39.1 ± 23.6	49.8 ± 32.8
Ferritin, ng/mL	47.82 ± 26.41	109.88 ± 98.0	15.15 ± 10.11	62.71 ± 73.16
ESR, mm/h	39 ± 23	51 ± 18	63 ± 18	48 ± 22
CRP, mg/dL	1.38 ± 1.56^*	3.57 ± 4.12	2.12 ± 2.12	2.35 ± 2.98
RF (positive)	9	8	6	23
Medication
Methotrexate^†	17	15	8	40
Corticosteroids^‡	4	5	2	11

HAQ indicates Health Assessment Questionnaire48; MCV, mean corpuscular volume; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; RF, rheumatoid factor.

Values are expressed as mean ± 1 SD.

†

15-20 mg/weekly.

‡

5-10 mg/daily.

View Large

This Feature Is Available To Subscribers Only